Carotid imaging can provide information on the thickness of the vessels, expressed as the carotid intimamedia thickness (CIMT), and the presence of plaque. Information concerning both has been associated with incident CV events. 1 A recent meta-analysis highlights the variability in CIMT measurements across studies. 2 Quality assurance (QA) in imaging acquisition is crucial to avoid bias and minimise measurement variation over time. Here, the development of a QA process in the carotid ultrasound scanning protocol used within the UK Biobank Imaging Enhancement Study is described, along with the evaluation of this process from the first 2560 participants. 3 Application of these procedures reduced the number of quality fails within scans and helped to ensure that the majority (98%) of participants had at least one CIMT measure.
Arterial stiffness
Arterial stiffness is associated with the presence of CV risk factors and atherosclerotic disease in healthy adults and people with disabilities. 4 The association between arterial stiffness measurements and lifestyle-related factors, body composition and cardiorespiratory fitness in healthy Swedish adults was studied, highlighting the presence of an inverse association between cardiorespiratory fitness and arterial stiffness in young adults. 5 This confirms the importance of maintaining, or striving for, a high fitness level. 1 The association between cardiorespiratory fitness and arterial stiffness, had already been observed in young adults. 6 A novel finding was that underweight individuals were in a potential high-risk group that needs further investigation.
Another study assessed arterial stiffness in a population of preschool children using a non-invasive oscillometric device (Arteriograph): 7 this device gave at least one valid arterial stiffness measurement in only 59.3% of this population, showing sub-optimal feasibility. The observation that height was the most important determinant of stiffness is in contrast with other evidence which, using different devices, showed greater roles for age and weight. 8 
CV risk factors
A significant increase in the proportion of first-time ST elevation myocardial infarction (STEMI) patients without standard modifiable CV risk factors (RFs: hypercholesterolaemia, hypertension, diabetes and smoking) is reported. 9 The proportion of STEMI patients with zero RFs was 25% and, this proportion was increasing (by an odds ratio (OR) of 1.12 per year during the eight-year study period). In addition, these patients appear to have similar myocardial infarction (MI)related characteristics to those with RFs, with similar peak creatinine kinase, ejection fraction and duration of in-hospital stay. This highlights the need for bold approaches to discover new mechanisms and markers to enable early identification of these patients, as well as to understand the outcomes and develop new targeted therapies. In an accompanying commentary, the need to draw the attention of researchers to emerging environmental RFs, focusing on microwave radiofrequency electromagnetic radiation is discussed. 10 
Air pollution and healthy environment
The importance of a healthy environment is recommended in an invited editorial with practical implications for the clinical cardiologist in advising individuals at high risk of CV disease, or with actual clinical manifestations, to be closely adherent to their prescribed medications, particularly during periods of more intense air pollution. 11 
Marijuana use
Marijuana use, especially prolonged years of use, was associated with an increased risk of hypertension mortality. 12 This risk could be greater than the CV risk already established for cigarette smoking, suggesting that, without disputing the possible medicinal benefits of standardised cannabis formulations, recreational use of marijuana should be approached with caution.
Health literacy
In people with CV disease, a low level of education is associated with higher prevalence of many CV RFs which may be due to lower awareness. 13 A large and comprehensive analysis of the relationship between health literacy and health behaviour has shown significant associations between health literacy and increased physical activity, healthier diet and higher self-reported health status, better weight control, and abstinence from smoking, in individuals with CV disease. 14 
Lipid-lowering therapy
A modelling analysis of the potential effect of lomitapide, on major adverse CV events and survival in homozygous familial hypercholesterolaemia (HoFH) was studied. Lomitapide is a microsomal triglyceride transfer protein inhibitor that has been shown to decrease low-density lipoprotein (LDL)-cholesterol levels in HoFH patients. Poor evidence of the clinical benefit of lowering LDL cholesterol for patients with HoFH exists, given its rarity. The analysis suggests that lifetime lomitapide treatment could increase median life expectancy by 11.7 years and time to first major adverse CV events by 6.7 years. 15 However, the accompanying comment observes that such indirect evaluation did not assess the safety issues and, as a consequence, the real benefit/risk ratio of the treatment. 16 The most common reported adverse event is gastrointestinal disorder, although liver transaminase elevation and hepatic fat accumulation have also been described, and long-term safety remains to be carefully analysed.
Baragetti et al. 17 compared body mass index (BMI), total and visceral fat mass in 13 patients carrying the R46L LOF mutation of the PCSK9 gene with a cohort of 521 non-carriers in the Progressione della Lesione Intimale Carotidea (PLIC) study. In R46L LOF mutation carriers, LDL-cholesterol levels were only moderately reduced but there were increased BMI and waist-to-hip ratio observations, and total fat mass with an increased percentage of fat accumulation in the android region. These findings are highly relevant for the future clinical application of PCKS9 inhibitors because visceral fat has been shown to have endocrine activity through the release of adipokines (e.g. leptin) which influence energy and glucose metabolism and are involved in the metabolic syndrome. 18 
Physical exercise as a therapy
Regular exercise training leads to a favourable risk factor profile, improves CV function and lowers the risk of CV disease. 19 Despite the cardio-protective effects of training, athletes are not exempted from acute coronary syndromes. However, the deleterious effects of MI seem to be reduced by lifelong exercise training, as shown in the study of Maessen et al. 20 Thus physical training, protects not only against CV injury, but it also reduced the damage after injury.
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